Bank of New York Mellon Corp boosted its position in OvaScience Inc. (NASDAQ:OVAS) by 34.1% during the second quarter, Holdings Channel reports. The institutional investor owned 156,388 shares of the company’s stock after buying an additional 39,767 shares during the period. Bank of New York Mellon Corp owned approximately 0.57% of OvaScience worth $815,000 as of its most recent filing with the SEC.
Several other institutional investors have also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. raised its stake in shares of OvaScience by 2.8% in the first quarter. JPMorgan Chase & Co. now owns 341,789 shares of the company’s stock worth $3,243,000 after buying an additional 9,350 shares during the last quarter. Northern Capital Management LLC raised its stake in shares of OvaScience by 61.0% in the second quarter. Northern Capital Management LLC now owns 30,340 shares of the company’s stock worth $158,000 after buying an additional 11,500 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of OvaScience by 9.1% in the first quarter. Geode Capital Management LLC now owns 164,168 shares of the company’s stock worth $1,557,000 after buying an additional 13,699 shares during the last quarter. Stoneridge Investment Partners LLC raised its stake in shares of OvaScience by 120.4% in the second quarter. Stoneridge Investment Partners LLC now owns 49,960 shares of the company’s stock worth $260,000 after buying an additional 27,291 shares during the last quarter. Finally, Quantitative Systematic Strategies LLC bought a new stake in shares of OvaScience during the second quarter worth $164,000. 80.71% of the stock is owned by hedge funds and other institutional investors.
OvaScience Inc. (NASDAQ:OVAS) traded up 2.24% during midday trading on Tuesday, hitting $6.38. 56,398 shares of the stock traded hands. The company’s 50-day moving average is $7.10 and its 200 day moving average is $7.00. OvaScience Inc. has a 12-month low of $4.53 and a 12-month high of $14.95. The firm’s market cap is $226.88 million.
OvaScience (NASDAQ:OVAS) last announced its earnings results on Thursday, August 4th. The company reported ($0.62) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.78) by $0.16. The company earned $0.19 million during the quarter, compared to analyst estimates of $0.21 million. OvaScience had a negative net margin of 13,906.35% and a negative return on equity of 60.10%. OvaScience’s revenue was up 530.0% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.64) earnings per share. On average, analysts anticipate that OvaScience Inc. will post ($2.66) EPS for the current fiscal year.
A number of brokerages recently weighed in on OVAS. JPMorgan Chase & Co. decreased their price objective on shares of OvaScience from $9.00 to $8.00 and set a “neutral” rating for the company in a report on Friday, August 5th. JMP Securities reiterated a “neutral” rating on shares of OvaScience in a report on Wednesday, August 10th. Zacks Investment Research upgraded shares of OvaScience from a “hold” rating to a “buy” rating and set a $7.00 price objective for the company in a report on Wednesday, August 10th. Finally, Credit Suisse Group AG reiterated a “sell” rating on shares of OvaScience in a report on Tuesday, July 12th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $10.31.
OvaScience, Inc is a global fertility company. The Company is focused on the discovery, development and commercialization of fertility treatment options for women. The Company’s portfolio of fertility treatment options uses its technology, including methods to identify and isolate Egg precursor (EggPC) cells from a patient’s own ovarian tissue.
Want to see what other hedge funds are holding OVAS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for OvaScience Inc. (NASDAQ:OVAS).
Receive News & Ratings for OvaScience Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OvaScience Inc. and related companies with MarketBeat.com's FREE daily email newsletter.